Standard
Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients-COVIDOUT study. / Schönlein, Martin; Wrage, Victoria; Ghandili, Susanne; Mellinghoff, Sibylle C; Brehm, Thomas Theo; Leypoldt, Lisa B; Utz, Nils; Schrader, Roland M; Alsdorf, Winfried; Börschel, Niklas; Bußmann, Lara; Schönrock, Martin; Perlick, Dorothea; Schön, Gerhard; Verpoort, Karl; Lütgehetmann, Marc; Schulze Zur Wiesch, Julian; Weisel, Katja C; Bokemeyer, Carsten; Schafhausen, Philippe; Sinn, Marianne.
In:
CANCER CELL, Vol. 40, No. 6, 13.06.2022, p. 581-583.
Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
Harvard
Schönlein, M, Wrage, V
, Ghandili, S, Mellinghoff, SC
, Brehm, TT, Leypoldt, LB, Utz, N, Schrader, RM
, Alsdorf, W, Börschel, N, Bußmann, L
, Schönrock, M, Perlick, D
, Schön, G, Verpoort, K
, Lütgehetmann, M, Schulze Zur Wiesch, J, Weisel, KC, Bokemeyer, C, Schafhausen, P & Sinn, M 2022, '
Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients-COVIDOUT study',
CANCER CELL, vol. 40, no. 6, pp. 581-583.
https://doi.org/10.1016/j.ccell.2022.04.016
APA
Schönlein, M., Wrage, V.
, Ghandili, S., Mellinghoff, S. C.
, Brehm, T. T., Leypoldt, L. B., Utz, N., Schrader, R. M.
, Alsdorf, W., Börschel, N., Bußmann, L.
, Schönrock, M., Perlick, D.
, Schön, G., Verpoort, K.
, Lütgehetmann, M., Schulze Zur Wiesch, J., Weisel, K. C., Bokemeyer, C., ... Sinn, M. (2022).
Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients-COVIDOUT study.
CANCER CELL,
40(6), 581-583.
https://doi.org/10.1016/j.ccell.2022.04.016
Vancouver
Bibtex
@article{99ca0104e5d942289d82a6361bf64a81,
title = "Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients-COVIDOUT study",
author = "Martin Sch{\"o}nlein and Victoria Wrage and Susanne Ghandili and Mellinghoff, {Sibylle C} and Brehm, {Thomas Theo} and Leypoldt, {Lisa B} and Nils Utz and Schrader, {Roland M} and Winfried Alsdorf and Niklas B{\"o}rschel and Lara Bu{\ss}mann and Martin Sch{\"o}nrock and Dorothea Perlick and Gerhard Sch{\"o}n and Karl Verpoort and Marc L{\"u}tgehetmann and {Schulze Zur Wiesch}, Julian and Weisel, {Katja C} and Carsten Bokemeyer and Philippe Schafhausen and Marianne Sinn",
year = "2022",
month = jun,
day = "13",
doi = "10.1016/j.ccell.2022.04.016",
language = "English",
volume = "40",
pages = "581--583",
journal = "CANCER CELL",
issn = "1535-6108",
publisher = "Cell Press",
number = "6",
}
RIS
TY - JOUR
T1 - Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients-COVIDOUT study
AU - Schönlein, Martin
AU - Wrage, Victoria
AU - Ghandili, Susanne
AU - Mellinghoff, Sibylle C
AU - Brehm, Thomas Theo
AU - Leypoldt, Lisa B
AU - Utz, Nils
AU - Schrader, Roland M
AU - Alsdorf, Winfried
AU - Börschel, Niklas
AU - Bußmann, Lara
AU - Schönrock, Martin
AU - Perlick, Dorothea
AU - Schön, Gerhard
AU - Verpoort, Karl
AU - Lütgehetmann, Marc
AU - Schulze Zur Wiesch, Julian
AU - Weisel, Katja C
AU - Bokemeyer, Carsten
AU - Schafhausen, Philippe
AU - Sinn, Marianne
PY - 2022/6/13
Y1 - 2022/6/13
U2 - 10.1016/j.ccell.2022.04.016
DO - 10.1016/j.ccell.2022.04.016
M3 - Other (editorial matter etc.)
C2 - 35512712
VL - 40
SP - 581
EP - 583
JO - CANCER CELL
JF - CANCER CELL
SN - 1535-6108
IS - 6
ER -